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ctivating ~~~o~rot~~~ lipase in ca 
breakdown and increase free fatty 
shown to increase ve~t~~c~~~~ .hmct 
graphy, would document whether low molecular weight heparin 
treatment increased collateral Bow. owever, a more formidable 
task will be to prove that this drug promotes or modulates actual 
angiogenesis in humans. 
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more severe ISC 
t be due to chauges in 
of myocardial ischemia in patients with coronary artery disease, we 
resorted to three different tests: treadmi!~ exercise testing, ambula- 
tory ST segment monitoring and exercise radio~~c~ide v 
raphy. ultivariate analysis was Reformed to detect 
preselected five variables 
indexes of collateral func 
administration, even wh 
neity among the patients. 
to elucidate what the siz 
full-scale definitive study, given the variability of patients with 
coronary artery disease. 
As previously, the improvement seen in our patients is most 
likely, but certainly not definitively, due to au increase in collateral 
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lieve that he study serves as a useful prelimi- 
nary step to examine this novel approach for treatment of myocar- 
dial ischemia. 
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